The forecast for mortality rates due to colon, rectum, and anus malignant neoplasms in Canada indicates a decline from 20.3 deaths per 100,000 persons in 2024 to 19.0 in 2028. This presents a year-on-year reduction of approximately 1.97% for 2025, 1.51% for 2026, 1.53% for 2027, and 1.55% for 2028, reflecting a steady decrease each year. The compounded annual growth rate (CAGR) over this period highlights a mean yearly decrease of 1.65%.
Future trends to watch for include advancements in early detection techniques, improved treatment methods, and public health initiatives aimed at prevention and awareness. Additionally, demographic changes and healthcare access improvements may further influence these mortality rates.
